Use of complementary/alternative medicine by patients with breast carcinoma;Anwendung komplementärer/alternativer therapiemassnahmen bei patientinnen mit brustkrebs

Forschende Komplementarmedizin und Klassische Naturheilkunde

Volumn 10, Issue 6, 2003, Pages 304-308

  Schonekaes K ^a,h   Micke, O ^a,b   Mucke R ^a,c   Buntzel J ^a,d   Glatzel, M ^a,e   Bruns, F ^a,f   Kisters, K ^a,g  

^a Arbeitskreis Trace Elements E   (Germany)

^b UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^c Klinikum Weiden   (Germany)

^d HNO Klinik   (Germany)

^e Klinik fur Strahlentherapie   (Germany)

^f Clemenshospital Munster   (Germany)

^g ST ANNA HOSPITAL   (Germany)

^h NONE   (Germany)

Author keywords

Breast carcinoma; Minerals; Mistletoe therapy; Vitamins

Indexed keywords

MINERAL; VISCUM ALBUM EXTRACT;

ADULT; AGE DISTRIBUTION; AGED; ALTERNATIVE MEDICINE; ARTICLE; BREAST CARCINOMA; CANCER LOCALIZATION; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RECURRENCE; FEMALE; GENERAL PRACTITIONER; GYNECOLOGY; HUMAN; IMMUNE SYSTEM; MAJOR CLINICAL STUDY; MASTECTOMY; MULTIMODALITY CANCER THERAPY; TREATMENT OUTCOME; VITAMIN SUPPLEMENTATION;

ADULT; AGED; BREAST NEOPLASMS; CARCINOMA; COMPLEMENTARY THERAPIES; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; RADIOTHERAPY, ADJUVANT;

EID: 1642453570     PISSN: 14247364     EISSN: None     Source Type: Journal    
DOI: 10.1159/000075883     Document Type: Article

References (30)

1. Micke O: Quo vadis trace elements? History and future of trace elements in radiation oncology. Trace Elem Electrolytes 2000;17:187-189.
2. Petru E, Schmied P, Petru C: Komplementäre Massnahmen bei Patienten mit gynäkologischen Malignomen unter Chemo- und Hormontherapie -Bestandsaufnahme und kritische Überlegungen für die Praxis. Geburtshilfe Frauenheilkd 2001;61:75-78.
3. Eisenberg DM, Kessler RC, Foster C, Norlock FE, Calkins DR, Delbanco TL: Unconventional medicine in the United States. Prevalence, costs and patterns of use. N Engl J Med 1993;328:246-252.
4. Astin JA: Why patients use alternative medicine: Results of a national study. JAMA 1998;279:1548-1553.
5. Fischer P, Ward A: Complementary medicine in Europe. Br Med J 1994;309:107-111.
6. Fuhljahn C, Trams G: Komplementare Behand-lungsmethoden in der gynäkologischen Onkologie. Frauenarzt 1999;40:1035-1038.
7. Münstedt K, Kirsch K, Milch W, Sachse S, Vahrson H: Unconventional cancer therapy-survey of patients with gynaecological malignancy. Arch Gynecol Obstet 1996;258:81-88.
8. Sehouli J, David M, Kaufmann B, Lichtenegger W: Unkonventionelle Methoden in der Krebsmedizin- Postoperative Nutzung durch Patienten mit gynäkologischen Malignomen. Geburtshilfe Frauenheilkd 2000;60:147-154.
9. Boon H, Stewart M, Kennard MA, Gray R, Sawka C, Brown JB, McWilliam C, Gavin A, Baron RA, Aaron D, Haines-Kamka T: Use of complementary/alternative medicine by breast cancer survivors in Ontario: Prevalence and perceptions. J Clin Oncol 2000;18:2515-2521.
10. Burstein HJ: Discussing complementary therapies with cancer patients: What should we be talking about. J Clin Oncol 2000;18:2501-2504.
11. Grothey A, Düppe J, Hasenburg A, Voigtmann R: Anwendung alternativmedizinischer Methoden durch onkologische Patienten. Dtsch Med Wochenschr 1998;123:923-929.
12. Schönekaes K, Schüller P, Micke O, Mücke R, Büntzel J, Bruns F, Kisters K, Panke J, Wagner W: An analysis of complementary/ alternative medicine (CAM) use by radiotherapy patients. Trace Elem Electrolytes 2001;18:181-185.
13. Nagel GA: Naturheilkunde als Metapher. Schweiz Rundsch Med Prax 1993;83:735-739.
14. Eisenberg DM, Davis RB, Ettner SL, Appel S, Wilkey S, Van Rompay M, Kessler RC: Trends in alternative medicine use in the United States 1990-1997: Results of a follow-up national survey. JAMA 1998;280:1569-1575.
15. Steuer-Vogt MK, Bonkowsky V, Scholz M, Amold W: Plattenepithelkarzinome des Kopf-Hals-Bereichs. Mistellektin-1-normierte Viscumtherapie. Dtsch Ä rzetbl 2001;46:A3036-3046.
16. Adler SR, Foskett JR: Disclosing complementary and alternative medicine use in the medical encounter: A qualitative study in women with breast cancer. J Fam Pract 1999;48:453-458.
17. Cunningham AJ, Edmonds CVI, Jenkins GP, Pollack H, Lockwood GA, Warr D: A randomized controlled trial of the effects of group psychological therapy on survival in women with metastatic breast cancer. Psychooncology 1998;7:508-517.
18. Downer SM, Cody MM, McClusky P, Wilson PD, Amott SJ, Lister TA, Slevin ML: Pursuit and practice of complementary therapies by cancer patients receiving conventional treatment. BMJ 1994;309: 86-89.
19. Richardson MA, Sanders T, Palmer JL, Greisinger A, Singletary SE: Complementary/alternative medicine use in a comprehensive cancer center and the implications for oncology. J Clin Oncol 2000;18: 2505-2514.
20. Lerner IJ, Kennedy BJ: The prevalence of questionable methods of cancer treatment in the United States. CA Cancer J Clin 1992;42:181-191.
21. Risberg T, Lund E, Wist E, Dahl O, Sundstrom S, Andersen OK, Kaasa S: The use of non-proven therapy among patients in Norwegian oncological departments: A cross-sectional national multicenter study. Eur J Cancer 1995:31A:1785-1789.
22. Begbie SD, Kerestes ZL, Bell DR: Patterns of alternative medicine use by cancer patients. Med J Aust 1996;165:545-548.
23. Berger DP, Obrist J, Obrecht JP: Tumorpatient und Paramedizin. Versuch einer Charakterisierung von Anwendern unkonventioneller Therapieverfahren in der Onkologie. Dtsch Med Wochenschr 1989; 114:323-330.
24. Wies J, Bartsch H, Hennies F: Complementary medicine in cancer patients: Demand, patients attitude, and psychological belief. Onkologie 1998;21: 144-149.
25. Wyatt GK, Friedman LL, Given CW, Given BA, Beckrow KC: Complementary therapy use among older cancer patients. Cancer Pract 1999;7:136-144.
26. Burstein HJ, Selber S, Guadagnoli E, Weeks JC: Use of alternative medicine by women with early-stage breast cancer. N Engl J Med 1999;340:1773-1739.
27. Verhoef MJ, Hagen N, Pelletier G, Forsyth P: Alternative therapy use in neurologic diseases: Use in brain tumor patients. Neurology 1999;52:617-622.
28. Sehlen S, Hollenhorst H, Schymura B, Firsching M, Aydemir U, Herschbach P, Dühmke E: Krank-heitsspezifische Belastung von Tumorpatienten zu Beginn einer Strahlentherapie. Strahlenther Onkol 2001;177:530-537.
29. Coss RA, McGrath P, Caggiano V: Alternative care: Patient choices for adjunct therapies within a cancer center. Cancer Pract 1998;6:176-181.
30. Labriola D, Livingston R: Possible interactions between dietary antioxidants and chemotherapy. Oncology 1999;13:1003-1008.